Amgen Inc. (AMGN) BofA Securities 2025 Healthcare Conference (Transcript)

  • Amgen Inc. (NASDAQ:AMGN ) BofA Securities 2025 Healthcare Conference Call May 14, 2025 12:20 PM ET Company Participants Peter Griffith - Executive Vice President and Chief Financial Officer Justin Claeys - Vice President of Investor Relations James Bradner - Executive Vice President of Research and Development Conference Call Participants Tim Anderson - Bank of America Merrill Lynch Tim Anderson Thanks for joining us. I'm Tim Anderson, the U.S. large pharma and biotech analyst at Bank of America.